KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Notes Payables (2016)

Bristol Myers Squibb has reported Notes Payables over the past 8 years, most recently at $155.0 million for Q2 2016.

  • Quarterly Notes Payables fell 79.47% to $155.0 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $155.0 million through Jun 2016, down 79.47% year-over-year, with the annual reading at $139.0 million for FY2015, 76.44% down from the prior year.
  • Notes Payables was $155.0 million for Q2 2016 at Bristol Myers Squibb, up from $106.0 million in the prior quarter.
  • Over five years, Notes Payables peaked at $1.4 billion in Q1 2013 and troughed at $106.0 million in Q1 2016.
  • The 5-year median for Notes Payables is $383.0 million (2014), against an average of $494.3 million.
  • Year-over-year, Notes Payables surged 846.21% in 2013 and then plummeted 79.52% in 2014.
  • A 5-year view of Notes Payables shows it stood at $826.0 million in 2012, then crashed by 56.54% to $359.0 million in 2013, then surged by 64.35% to $590.0 million in 2014, then plummeted by 76.44% to $139.0 million in 2015, then rose by 11.51% to $155.0 million in 2016.
  • Per Business Quant, the three most recent readings for BMY's Notes Payables are $155.0 million (Q2 2016), $106.0 million (Q1 2016), and $139.0 million (Q4 2015).